eMEMBERSHIP  LOGIN

Stem Cell Therapy Effective for Type-1 Diabetes

Posted on Jan. 26, 2012, 6 a.m. in Stem Cell Diabetes

Among patients with Type-1 diabetes, therapy using the patient's lymphocytes passed through a device with cord blood stem cells “re-educated” the patient's cells, suggesting a potential safe, lasting treatment for the disease.  Yong Zhao, from University of Illinois/Chicago (Illinois, USA), and colleagues completed a study involving 15 subjects, 12 of whom received the treatment, finding that lymphocytes "re-educated" by passage with cord blood stem cells were effective in treating patients with type 1 diabetes with and without residual beta cell function.  As well, both insulin requirements and glycated hemoglobin levels decreased significantly in the treated patients with effects lasting out to 40 weeks.  Submitting that: “Stem Cell Educator therapy is safe, and in individuals with moderate or severe [Type-1 diabetes], a single treatment produces lasting improvement in metabolic control,” the study authors conclude that: “Initial results indicate Stem Cell Educator therapy reverses autoimmunity and promotes regeneration of islet beta cells.”

View news source…

Yong Zhao, Zhaoshun Jiang, Tingbao Zhao, Mingliang Ye, Chengjin Hu, Zhaohui Yin, et al.  “Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells.”  BMC Medicine 2012, 10:3, 10 January 2012.

  

Health Headlines MORE »

The amount of choline needed by people varies significantly and is dependent upon their gender, life stage, race and ethnicity.
People who develop diabetes and high blood pressure in middle-age are at increased risk of brain damage and problems with thinking skills later in life.
Currently available drugs may help women at high risk of breast and ovarian cancers avoid the need for radical preventive surgery.
People who experience chronic sleep disturbances may be at risk of developing dementia and Alzheimer’s disease at an earlier age.
Bariatric surgery can dramatically reduce an obese person's risk of all-cause mortality and nearly halve their risk of heart attack and stroke.
Compounds in peaches may inhibit the growth of breast cancer cells and their ability to spread.
Older people who have above-average muscle mass also have a significantly lower risk of dying from all-causes.
Chemotherapy may accelerate molecular aging to the equivalent to 15-years of normal aging.
Long after compulsory schooling ends, education continues to enhance cognitive functions.
A self-rated poor level of fitness in a person’s 50s may predict onset of dementia within the next three decades.